Bluechiip Limited

ASX:BCT ISIN:AU000000BCT7

Bluechiip Ltd ASX BCTBluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.

Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.

Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.

Bluechiip: Delivering confidence in every sample.

 

 
    
            

View in Other Languages

News

Bluechiip Limited (ASX:BCT) FY22 Annual Report

🕔8/26/2022 9:47:37 AM 2870

Bluechiip Limited (ASX:BCT) (FRA:1BL) understands that every biological sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing

🕔7/28/2022 10:45:11 AM 1835

Open Briefing interview with Bluechiip Limited (ASX:BCT) MD Andrew McLellan.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔7/28/2022 10:41:31 AM 4241

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the company's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 June 2022.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing

🕔4/28/2022 3:03:18 PM 1649

Open Briefing interview with Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan. In this Open Briefing Andrew discusses sales growth accelerating and expected to continue, following the launch of Bluechiip's own product range in November 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔4/28/2022 2:58:43 PM 1373

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release the Group's Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 March 2022.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing Interview with MD Andrew McLellan

🕔1/27/2022 9:54:20 AM 2854

In this Open Briefing(R), Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses cash receipts from initial orders and deliveries of own product range, expectation for increasing revenues based on existing orders and growing enquiry pipeline, new patent award and developer kit sales and OEM negotiations.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔1/27/2022 9:49:25 AM 2359

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 31 December 2021.

Read Full Article

Bluechiip Limited (ASX:BCT) Secures FDA Registration and CE IVD Certification

🕔11/30/2021 10:05:01 AM 4118

Bluechiip Limited (ASX:BCT) (FRA:1BL), a leader in the development of advanced sample management solutions for harsh environments, today announced the recent registration of Bluechiip's own branded cryovials with the United States.

Read Full Article

Bluechiip Limited (ASX:BCT) Open Briefing Interview with Andrew McLellan

🕔10/28/2021 4:28:58 PM 3306

In this Open Briefing(R) interview, Bluechiip Limited (ASX:BCT) (FRA:1BL) MD Andrew McLellan discusses the September quarter 4C, License and Development agreement with US-based Fujifilm Irvine Scientific and the first sales of Bluechiip's own consumables.

Read Full Article

Bluechiip Limited (ASX:BCT) Quarterly Activities Report

🕔10/28/2021 4:24:23 PM 2206

Bluechiip Limited (ASX:BCT) (FRA:1BL) is pleased to release its Appendix 4C - Quarterly Cashflow report and update for the quarter ended 30 September 2021.

Read Full Article
###

105,403 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 249) (Last 30 Days: 882) (Since Published: 69921) 

Company Data

    Headquarters
  • 1 Dalmore Drive
    Caribbean Business Park
    Scoresby VIC 3179 AUSTRALIA
  • Telephone
  • +61-3-9763-9763 
  • Fax
  • +61-3-9763-9764 
  • Principal Sector
  • Infrastructure & Technology 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.bluechiip.com

Company Reports

More News Results

  • 2024/03/18: Change of Director's Interest Notice - AC*
  • 2024/03/18: Change of Director's Interest Notice - AM*
  • 2024/03/18: Becoming a substantial holder*
  • 2024/03/18: Change of Director's Interest Notice - IK*
  • 2024/03/18: Change of Director's Interest Notice - MOH*
  • 2024/03/14: Application for quotation of securities - BCT*
  • 2024/03/13: Response to ASX Query Letter*
  • 2024/03/12: Results of Entitlement Offer*
  • 2024/03/04: Investor Presentation*
  • 2024/02/29: Appendix 4D & Half Year Financial Report*
*refer to company website

Presentations

Download Presentation

Research Report

Download Presentation

Quarterly Report

Download Presentation

Social Media